Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reply: the early pathological process in sporadic Alzheimer's disease.

Literature DB >> 23982593

Reply: the early pathological process in sporadic Alzheimer's disease.

Heiko Braak¹, Kelly Del Tredici.

Abstract

Entities: Disease

Mesh：

Substances：
tau Proteins

Year: 2013 PMID： 23982593 DOI： 10.1007/s00401-013-1170-1

Source DB: PubMed Journal: Acta Neuropathol ISSN： 0001-6322 Impact factor: 17.088

Keyword Cloud
Cited

× No keyword cloud information.

15 in total

Review 1. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.

Authors: Harald Hampel; M-Marsel Mesulam; A Claudio Cuello; Martin R Farlow; Ezio Giacobini; George T Grossberg; Ara S Khachaturian; Andrea Vergallo; Enrica Cavedo; Peter J Snyder; Zaven S Khachaturian
Journal: Brain Date: 2018-07-01 Impact factor: 13.501

2. Emerging β-amyloid pathology and accelerated cortical atrophy.

Authors: Niklas Mattsson; Philip S Insel; Rachel Nosheny; Duygu Tosun; John Q Trojanowski; Leslie M Shaw; Clifford R Jack; Michael C Donohue; Michael W Weiner
Journal: JAMA Neurol Date: 2014-06 Impact factor: 18.302

Review 3. A fresh perspective from immunologists and vaccine researchers: active vaccination strategies to prevent and reverse Alzheimer's disease.

Authors: Michael G Agadjanyan; Nikolai Petrovsky; Anahit Ghochikyan
Journal: Alzheimers Dement Date: 2015-07-17 Impact factor: 21.566

Reply: the early pathological process in sporadic Alzheimer's disease.

Review 1. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.

2. Emerging β-amyloid pathology and accelerated cortical atrophy.

Review 3. A fresh perspective from immunologists and vaccine researchers: active vaccination strategies to prevent and reverse Alzheimer's disease.

Review 4. Heterogeneity in Alzheimer's Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials.

5. Hippocampal laminar distribution of tau relates to Alzheimer's disease and age of onset.

6. A standard model of Alzheimer's disease?

Review 7. Early failure of the default-mode network and the pathogenesis of Alzheimer's disease.

Review 8. Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer's Disease.

9. Amyloid and tau in the brain in sporadic Alzheimer's disease: defining the chicken and the egg.

Review 10. Models of β-amyloid induced Tau-pathology: the long and "folded" road to understand the mechanism.